Brief: Karuna Therapeutics Appoints Bill Meury As Chief Executive Officer
Dec 6 (Reuters) - Karuna Therapeutics Inc KRTX.O :
* KARUNA THERAPEUTICS APPOINTS BILL MEURY AS PRESIDENT AND
CHIEF
EXECUTIVE OFFICER
* KARUNA THERAPEUTICS INC - CHRISTOPHER COUGHLIN TO ASSUME
ROLE OF
CHAIRMAN OF BOARD
* KARUNA THERAPEUTICS INC - ANNOUNCED APPOINTMENT OF BILL
MEURY AS
PRESIDENT AND CEO AND A MEMBER OF COMPANY'S BOARD, EFFECTIVE
JANUARY 3, 2023
* KARUNA THERAPEUTICS - SUCCEEDS CURRENT CEO & CHAIRMAN,
STEVE
PAUL, WHO WILL TRANSITION TO PRESIDENT OF RESEARCH & DEVELOPMENT
& CHIEF SCIENTIFIC OFFICER
Source text for Eikon: ID:nBw8Y50Sna
Further company coverage: KRTX.O
Recent news on Karuna Therapeutics
See all newsMoody's says pharma outlook turns 'positive' on GLP-1 drug push
Brief: Karuna Therapeutics Says Complaint Was Filed By Karuna Stockholder Seeking To Enjoin Proposed Merger With Bristol-Myers Squibb
Karuna Therapeutics Inc reports results for the quarter ended in December - Earnings Summary
Karuna Therapeutics Inc expected to post a loss of $2.65 a share - Earnings Preview
Bristol Myers posts better-than-expected 4th-quarter results (updated)